Trial Profile
A phase III study of KUR-111 in patients with tibial plateau fractures
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 04 Sep 2015
Price :
$35
*
At a glance
- Drugs KUR-111 (Primary)
- Indications Fracture
- Focus Therapeutic Use
- 04 Sep 2015 Status changed from not stated to planning.
- 19 Aug 2015 New trial record